Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000950123-25-007031
Filing Date
2025-08-05
Accepted
2025-08-05 17:08:39
Documents
1
Effectiveness Date
2025-08-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 17912
  Complete submission text file 0000950123-25-007031.txt   19259
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-553778 | Film No.: 251186111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)